ACTIVE_NOT_RECRUITING

Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules

Conditions

Healthy Diet Algae Oil EPA and DHA Omega-3 Fatty Acids

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will compare the algae oil fortified soymilk to a commercial algae oil capsule containing the same base oil with the goal of demonstrating equivalent or greater accumulation of EPA and DHA in blood lipid pools.

Official Title

Bioavailability and Pharmacodynamics of Eicosapentaenoic Acid and Docosahexaenoic Acid in Soymilk and Commercial Supplements

Quick Facts

Study Start:2023-04-03

Study Completion:2026-07-10

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05802797

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Body mass index between 18 and 30 kg/m2	* Being pregnant or nursing * Having anemia or a condition that influences the ability to donate blood safely * Allergies to the beverage or pill ingredients * Diabetes * High triglycerides or cholesterol * Coagulation disorder * Anticoagulation therapy or any drug that affects blood clotting. * Taking prescribed dietary omega-3 fatty acid medications including fish oil or algae oil within the last 3 months * Taking non-prescribed dietary omega-3 fatty acid supplements within the last 3 months and not willing to discontinue taking them for the study period * Taking lipid lowering medications such as statins * Sensory impairments which affect ability to taste, smell, or see food products

Inclusion Criteria

Exclusion Criteria

* Body mass index between 18 and 30 kg/m2

* Being pregnant or nursing
* Having anemia or a condition that influences the ability to donate blood safely
* Allergies to the beverage or pill ingredients
* Diabetes
* High triglycerides or cholesterol
* Coagulation disorder
* Anticoagulation therapy or any drug that affects blood clotting.
* Taking prescribed dietary omega-3 fatty acid medications including fish oil or algae oil within the last 3 months
* Taking non-prescribed dietary omega-3 fatty acid supplements within the last 3 months and not willing to discontinue taking them for the study period
* Taking lipid lowering medications such as statins
* Sensory impairments which affect ability to taste, smell, or see food products

Contacts and Locations

Principal Investigator

Yael Vodovotz, PhD

PRINCIPAL_INVESTIGATOR

Ohio State University

Study Locations (Sites)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210

United States

Collaborators and Investigators

Sponsor: Ohio State University Comprehensive Cancer Center

Yael Vodovotz, PhD, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-03

Study Completion Date2026-07-10

Study Record Updates

Study Start Date2023-04-03

Study Completion Date2026-07-10

Terms related to this study

Keywords Provided by Researchers

Algae Oil
EPA and DHA
Omega-3 Fatty Acids

Additional Relevant MeSH Terms

Healthy Diet